Nuvectis Pharma Inc. logo

Nuvectis Pharma Inc.

NVCT | NASDAQ
Chart Builder DCF Calculator
$22.40
+$0.42 (+1.91%)
Sep 22, 2026, 10:33 AM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-7.2M -6.26M -7.62M -7.79M -6.6M -5.57M -6.45M -4.36M -4.64M -4.4M -6.87M -6.16M -5.77M -4.1M -6.78M -5.94M -3.57M -2.95M -2.27M -4.67M -5.94M -23K
Interest Income
177K 210K -829K 332K 261K 236K 201K 206K 215K 225K 244K 277K 64K 52K 82K 61K 4K 2K 4K n/a n/a n/a
Pretax Income
-7.02M -6.05M -7.31M -7.46M -6.33M -5.33M -6.25M -4.15M -4.43M -4.17M -6.62M -5.88M -5.71M -4.05M -6.7M -5.88M -3.57M -2.94M -2.26M -4.67M -5.94M -23K
Net Income
-7.02M -6.05M -7.31M -7.46M -6.33M -5.33M -6.25M -4.15M -4.43M -4.17M -6.62M -5.88M -5.71M -4.05M -6.7M -5.88M -3.57M -2.94M -2.26M -4.67M -5.94M -23K
Selling & General & Admin
2.51M 2.15M 2.53M 2.02M 2.98M 1.89M 1.95M 1.54M 1.7M 1.74M 2.6M 1.67M 1.51M 1.73M 2.38M 1.42M 1.07M 1.14M 1.12M 512K 1.69M 23K
Research & Development
4.68M 4.11M 5.09M 5.77M 3.61M 3.68M 4.5M 2.82M 2.94M 2.66M 4.27M 4.49M 4.26M 2.37M 4.4M 4.52M 2.51M 1.81M 1.14M 4.16M 4.25M n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
7.2M 6.26M 7.62M 7.79M 6.6M 5.57M 6.45M 4.36M 4.64M 4.4M 6.87M 6.16M 5.77M 4.1M 6.78M 5.94M 3.57M 2.95M 2.27M 4.67M 5.94M 23K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.2M 6.26M 7.62M 7.79M 6.6M 5.57M 6.45M 4.36M 4.64M 4.4M 6.87M 6.16M 5.77M 4.1M 6.78M 5.94M 3.57M 2.95M 2.27M 4.67M 5.94M 23K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
23.48M 23.41M 21.81M 22.72M 21.37M 19.94M 19.5M 17.23M 16.9M 16.56M 17.42M 16.1M 15.18M 14.72M 14.64M 14.05M 12.72M 12.72M 12.72M 12.72M 12.72M 12.72M
Shares Outstanding (Diluted)
23.48M 23.41M 21.81M 22.72M 21.37M 19.94M 19.5M 17.23M 16.9M 16.56M 17.42M 16.1M 15.18M 14.72M 14.64M 14.05M 12.72M 12.72M 12.72M 12.72M 12.72M 12.72M
EPS (Basic)
-0.30 -0.26 -0.31 -0.44 -0.30 -0.27 -0.34 -0.24 -0.26 -0.25 -0.42 -0.37 -0.38 -0.27 -0.50 -0.42 -0.28 -0.32 -0.21 -0.39 -0.47 0
EPS (Diluted)
-0.30 -0.26 -0.31 -0.44 -0.30 -0.27 -0.34 -0.24 -0.26 -0.25 -0.42 -0.37 -0.38 -0.27 -0.50 -0.42 -0.28 -0.32 -0.21 -0.39 -0.47 0
EBITDA
-7.2M -6.05M -8.21M -7.46M -6.33M -5.33M -6.25M -4.15M -4.43M -4.17M -6.62M -5.88M -5.71M -4.05M -6.7M -5.88M -3.57M -2.94M -2.26M -4.67M -5.94M -23K
EBIT
-7.2M -6.05M -8.21M -7.46M -6.33M -5.33M -6.25M -4.15M -4.43M -4.17M -6.62M -5.88M -5.71M -4.05M -6.7M -5.88M -3.57M -2.94M -2.26M -4.67M -5.94M -23K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.